In this study, we demonstrate that correcting the monocyte adhesion defect in CFTR ΔF508 mice (CF mice) by bone marrow transplantation significantly improved survival and reduced inflammation.
Introduction
Cystic fibrosis (CF) is one of the most common monogenic diseases (more than 70,000 cases worldwide, ~1,000 new cases each year) (1) , which is caused by variations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. CFTR is an anion-conducting transmembrane channel that is very important in mucus function and the ion homeostasis of cells (2) . More than 2000 gene variants have been identified, which are grouped into six types of mutations (2) . In humans, CF disease is dominated by lung and pancreas pathologies. The dominant pathology in the lung is inflammation caused by failure to clear microorganisms and the generation of a toxic pro-inflammatory microenvironment (2) (3) (4) . CFTR dysfunction in the pancreas results in pancreatic insufficiency in most CF patients (2) .
CFTR mutations result in mucus dysfunction (5) and impaired mucocilliary clearance in sino-pulmonary tissue. The resulting viscous mucus becomes infected with pathogens, such as Pseudomonas aeruginosa (6) (7) (8) (9) , Staphylococcus aureus (10, 11) , Haemophilus influenza (12) , and Aspergillus species (13) . These recurrent infections greatly exacerbate the symptoms of CF (4, 5, 14) and impact patient quality of life. Current clinical management of CF includes prophylactic (flucloxacillin) and therapeutic antibiotics (nebulized tobramycin, colistin, and aztreonam), DNAse (Dornase alfa), CFTR potentiators and correctors (Ivacaftor, Lumacaftor), and mucus thinners (Hypertonic saline) (15) . Although progress has been made (16) , there is currently no cure for CF.
There are several mouse models of CF (17, 18) , in which the homologues of common human CFTR mutations have been knocked into the mouse CFTR locus. Here, we use the CFTR ΔF508 mouse (19) , a widely used and well-accepted mouse model of CF (20, 21) . The pathology in this model is dominated by intestinal pathology, which exhibits mucus accumulation in the crypts of Lieberkühn, goblet cell hypertrophy, hyperplasia, and eosinophilic concretion in the crypts, resulting in constipation and rectal prolapse (22) . Death ensues when constipation leads to an ileus.
A recent study reported that mutations of CFTR commonly found in CF patients cause a profound monocyte adhesion defect (23, 24) . The authors demonstrated expression of CFTR in human monocytes and found a significant defect of their integrin activation and static adhesion.
A similar defect of static adhesion was reported in CFTR ΔF508 mouse monocytes, resulting in a ~60% (human) or ~40% (mouse) loss of monocyte static adhesion. Activation of the three main monocyte integrins (25) , β 2 (α L β 2 , α M β 2 ) and α 4 (α 4 β 1 ), was found to be defective. Remarkably, this defect is restricted to monocytes, with no defect in neutrophils and a minor defect (~20-30%) in lymphocytes. These features and the molecular mechanism make it different from the known leukocyte adhesion deficiencies LAD I, II and III (26) , suggesting that CF is associated with a new leukocyte adhesion deficiency, LAD IV (24) .
Monocytes are important guardians of epithelial surfaces. They serve by directly secreting cytokines (27) and killing pathogens (28, 29) and can differentiate into macrophages and inflammatory dendritic cells (30) . Macrophages clear apoptotic debris (efferocytosis), secrete cytokines for tissue homeostasis and survey the environment (31) . When macrophages detect pathogens or danger signals, they directly phagocytose and kill bacteria (29, 32) . They also produce many inflammatory cytokines and chemokines that orchestrate the recruitment of other immune and inflammatory cells (27) , which are involved in both the inflammatory antimicrobial response, wound healing and fibrosis (33) . Dendritic cells migrate to the draining lymph nodes, where they present antigens to CD4 and CD8 T cells and thus control the adaptive immune response.
Given the expression of CFTR in monocytes (23) , and given the monocyte adhesion defect, we reasoned that monocyte recruitment to mucosal sites might be defective in CFTR ΔF508 mice (CF mice), resulting in weakened host defense and increased pathogen burden. Here, we report that this is indeed the case. We reasoned that correcting CFTR in monocytes might improve CF disease burden and clinical outcomes. To test this, we performed bone marrow transplantation (BMT) to generate mice that were defective in CFTR in hematopoietic cells, non-hematopoietic cells, both, or neither. We observed improvement of CF symptoms and longer survival in mice that received wild-type (WT) bone marrow (BM). Mechanistically, we show that CF monocytes have a severe recruitment defect to the intestinal lamina propria and the bronchoalveolar space. Since it is now possible to correct genetic defects in HSCs (34, 35) , autologous transfer of engineered HSCs or allogeneic BMT would seem a plausible potential treatment for patients with CF.
Results

Leukocytosis in CF mice and adhesion defect of CF monocytes
First, we confirmed that CF mice died spontaneously under SPF conditions. The first mice succumbed at 23 days of age, with half of all deaths occurring by 40 days and ~91% CF mice succumbing by 59 days (Fig. 1A) . Like wild-type (CFTR WT/WT ) mice, heterozygous mice (CFTR ΔF508/WT ) survived for at least 110 days. At the same age (paired comparison of littermates), CF mice had significantly lower body weights ( Monocytes express CD115 (Colony-stimulating factor 1 receptor, CSF1R) while Ly6G identifies neutrophils in mouse BM ( Fig. 1G ). Using monoclonal antibodies to CD115 (red) and Ly6G (cyan) allowed us to visualize monocytes and neutrophils in flow chambers coated with P-selectin (to support rolling (36, 37) ) and ICAM-1 (to support arrest(37)) ( Fig. 1H ). In these experiments, arrest was triggered by infusing CCL2 (Chemokine C-C motif ligand 2, also knowns as monocyte chemoattractant protein-1, MCP-1) at a concentration of 100 ng·mL -1 . The same number of WT or CF BM cells (5×10 7 mL -1 ) were perfused in the flow chambers. Rolling and arrest were monitored by epifluorescence microscopy. The total number of cells (monocytes plus neutrophils) per field-of-view (FOV) was the same in flow chambers perfused with WT or CF BM cells. The total number of monocytes per FOV was slightly less in the flow chambers perfused with CF than WT BM cells (Fig. 1I ). The number of arrested WT, but not CF monocytes, doubled in response to CCL2 ( Fig. 1I ). Thus, we conclude that CCL2-induced arrest under flow is completely abolished in CF monocytes.
Transplanting WT BM reliefs the disease in CF mice
Histological assessment of the small intestine revealed the previously described increased crypt depth and villus height in CF mice ( Fig. 2A ). For both parameters, the differences between CF and WT mice were significant ( Fig. 2B , C). CF mice also showed more mucus accumulation in the crypts of Lieberkühn than WT mice ( Fig. 2D ), resulting in a significantly larger percentage of crypts containing mucus ( Fig. 2E ).
Next, we asked whether reconstituting CFTR in monocytes was sufficient to improve the health of CF mice. To this end, we conducted BMT by injecting sterile WT or CF (control) BM cells into sub-lethally (700 rads) irradiated CF recipient mice. Reconstituting CF mice with WT BM resulted in 60-80% WT monocytes (Table S1 ) and significantly prolonged their survival ( Fig. 3A) . The median survival time increased from 34 to 99 days, and 33% of the mice survived for up to 225 days. Interestingly, all mice that survived to 110 days (80 days after BMT) remained alive for the entire experiment. Pathologic evaluation of the bone marrow-transplanted mice showed that reconstituting CF mice with WT BM restored the crypt height defect ( Fig. 3B , C), but not the villus height defect (Fig. 3D ). This treatment also reduced the mucus percentage as assessed by histology ( Fig. E, F ).
Transplanting CF BM induces the disease in WT mice
In a reverse approach, we tested whether the CFTR-dependent monocyte adhesion defect was sufficient to confer disease to WT mice. We reconstituted lethally (1100 rads) irradiated WT mice with CF or WT (control) BM (Fig. 4A ). In these mice, almost all hematopoietic cells are donor-derived (Table S1 ), but the epithelial cells are host-derived and thus retain intact, functional CFTR. All WT to WT control mice survived for the entire duration of the experiment (232 days), but half of the mice that were reconstituted with CF BM succumbed by 41 days.
Reconstituting WT mice with CF BM induced the crypt height defect ( Fig. 4B , C), but not villus height or mucus percentage ( Fig. D, E) . Thus, we conclude that CFTR ΔF508 in hematopoietic cells (by BMT of CFTR ΔF508 cells) significantly induces CF disease in WT mice.
The CFTR-dependent monocyte adhesion defect is both necessary and sufficient to drive CF disease in mice. The reconstitution efficiency of BM in mice upon the 1100 rads lethally irradiation was >90% (Table S1 ).
Recruitment defect of CF monocytes in vivo
Having shown the monocyte arrest defect under flow, we next asked whether this arrest defect translated into an in vivo monocyte recruitment defect of CF monocytes. To stringently investigate the recruitment of monocytes to the intestine and lung, we used mixed BM chimeras (37) . In these experiments, lethally irradiated WT mice were reconstituted with both WT and CF BM ( Fig. 5A) at an approximately 1:1 ratio, tracked by congenic markers (CD45.1/CD45.2). Both monocytes and macrophages were identified by flow cytometry (gating scheme in fig. S1-3). In unchallenged mice, there was no difference in the number of WT and CF monocytes in the lung (Fig. 5B ), but the lungs contained significantly more WT than CF macrophages ( Fig. 5C ), suggesting that the monocyte-to-macrophage differentiation may be defective in CF monocytes. To directly test monocyte recruitment in vivo, we challenged mixed CF/WT bone marrow chimeric mice with intranasal CCL2. Significantly more WT than CF monocytes appeared in the bronchoalveolar lavage fluid (BAL), demonstrating defective CF monocyte recruitment in vivo ( Fig. 5D ). This was also true for the Ly6C-hi subset of monocytes ( Fig. 5E ). In the small intestinal lamina propria, the findings were similar: we found no difference between WT and CF monocytes in unchallenged mice ( Fig. 5F ), but more WT than CF macrophages in lamina propria leukocytes (LPL, Fig. 5G ). Taken together, these findings indicate that the CF monocyte defect manifests in both elicited monocyte recruitment and in monocyte to macrophage differentiation.
DISCUSSION
This study reports mouse experiments demonstrating that BMT rescues the CF phenotype in the CFTR ΔF508 mouse model, suggesting that BMT could mitigate some aspects of CF disease by restoring monocyte/macrophage function and mucosal host defense. The survival and intestinal inflammation of CF mice were both improved by the hematological reconstitution using WT BM.
We show that CF monocytes fail to adhere under flow, show reduced recruitment in response to CCL2, and contribute less to macrophages in the lung and intestinal lamina propria than WT monocytes. We show that the CFTR ΔF508 in monocytes is both necessary and sufficient for full manifestation of CF disease.
Besides the recruitment defect, CF monocytes may have other functional defects when challenged by inflammation and infections. Upon LPS stimulation, monocytes from CF patients have been reported to show reduced inflammatory cytokine expression (lower TNFα, lower IL-6, lower IL-12, lower IL-23) and increased production of anti-inflammatory IL-10 compared to WT controls (38) . Taken together with our findings, this suggests complex defects encompassing arrest, recruitment, cytokine production and differentiation into macrophages. The common denominator of these defects may be defective β 2 integrin activation in CF monocytes, because β 2 integrins are known to be involved in many myeloid cell functions (39) .
Whether or not CF monocytes show defective phagocytosis remains controversial.
Complement-mediated phagocytosis of C3b-coated beads and Pseudomonas aeruginosa has been reported to be deficient in blood monocytes from CF patients (40) . In another study, the phagocytosis of Escherichia coli was increased in CF monocytes (38) . These findings suggest that some but not all phagocytosis mechanisms are affected by dysfunctional CFTR. Antigen presentation to CD4 T cells by MHC-II is decreased in CF monocytes (38) . A recent study showed that wild-type CFTR associates with PTEN, triggering the anti-inflammatory PI3K/Akt pathway in response to TLR4. This helps enhance Pseudomonas aeruginosa clearance (7), suggesting a mechanism that may fail in CF patients.
CFTR is expressed in the monocyte, but not the neutrophil plasma membrane (40) .
Consequently, CFTR deficiency did not affect the adhesion of human neutrophils (23) , which are the most abundant leukocytes in human blood and play essential roles in immune defense (37) .
However, CFTR mRNA is expressed in human neutrophils (41) . CFTR protein is found expressed in the phagolysosome membrane of neutrophils, which affects bacterial killing, degranulation and disease outcome (41) (42) (43) (44) (45) (46) . Thus, correcting CFTR by BMT may also restore the function of neutrophils and improve CF by promoting bacterial killing.
Four previous studies used BMT to ask whether stem cells existed that may restore CFTR function in lung (47) (48) (49) or gut (49, 50) epithelial cells. These studies showed that hematopoietic stem cells and multipotent mesenchymal stromal cells have the ability to home to the lung or intestine and differentiate into epithelial cells. A mild but significant rescue (~10%) of epithelial electrophysiology was shown in distal colons of CF mice, which have a decrease of Forskolin-induced transepithelial current compared to WT controls (49, 50) . However, the epithelial reconstitution was incomplete, even under the optimized conditions (47) . Optimized WT to CF BMT improved bacterial clearance and survival after infection with Pseudomonas aeruginosa (47) . In light of the present findings, it seems more likely that the benefit observed in (47) was due to the functional rescue of myeloid cell function rather than epithelial cell function.
Myeloid cell recruitment to the lung is a multi-step process, where the myeloid cells first leave the blood compartment to appear in the lung interstitium and then must negotiate the epithelial layer to appear in the bronchoalveolar lavage (51) . Our present findings suggest that the monocyte recruitment defect is localized to the transepithelial and not the transendothelial migration. The recruitment defect is not detected under homeostatic conditions but appears when mice are challenged with CCL2. CF patients likely are in a permanently challenged condition because of the bacterial load in the bronchoalveolar mucus. The mechanisms leading to a significantly reduced percentage of CF monocyte-derived macrophages in the lung and the intestinal lamina propria require further study.
Taken together, we show that restoration of WT monocytes is sufficient to improve health and survival in CF mice. Since many CF patients are diagnosed at a young age, and since BMT is more successful in children than in adults, this is an appealing strategy (52) . An antibody-based safer approach for BMT has been developed (53) , which might be suitable for testing our proposed CF treatment. Unlike in malignant diseases, lethal irradiation is not required and partial restoration with 60-80% WT monocytes is sufficient. Moreover, it is now possible to correct genetic defects in HSCs (34, 35) by gene therapy approaches, so that autologous transfer of engineered HSCs also may become a practical treatment for patients with CF.
MATERIALS AND METHODS
Reagents
Recombinant mouse P-selectin-Fc, ICAM-1-Fc and CCL2 were purchased from R&D Systems. 
BMT
WT/Het or CFTR Δ508 Recipients (C57BL/6J background littermates, male or female, one month old) were irradiated in two doses of 550 or 350 rads each (for a total of 1,100 or 700rads) four hours apart (RS-2000 X-Ray irradiator, Rad Source). Bone marrow cells from both femurs and tibias of donor mice (WT/Het or CFTR Δ508 mice, sex matched, one month old) were collected under sterile conditions. Bones were centrifuged for the collection of marrow, unfractionated bone marrow cells were washed, resuspended in PBS, injected retro-orbitally into the lethally irradiated mice (one donor to five recipients). Recipient mice were housed in a barrier facility under pathogen-free conditions before and after bone marrow transplantation. After bone marrow transplantation, mice were provided autoclaved acidified water with antibiotics (trimethoprim-sulfamethoxazole) and were fed autoclaved food. The survival of mice was monitored. Mice were used for further experiments eight weeks after bone marrow reconstitution.
In some experiment, DsRed WT mice were used as recipients or donors to test the reconstructive rate of BMT by flow cytometry.
In the mixed chimeric BMT, CD45.1/CD45.2 or WT C57BL/6J mice (eight weeks old males) were irradiated in two doses of 550 rads each (for a total of 1,100 rads) four hours apart (RS-2000 X-Ray irradiator, Rad Source). Bone marrow cells from both femurs and tibias of donor mice (CFTR Δ508 male and CD45.1 wild-type male, eleven weeks old) were collected under sterile conditions. Bones were centrifuged for the collection of marrow, unfractionated bone marrow cells were washed, resuspended in PBS, mixed at a ratio of 1:1 or 1:2, confirmed by flow cytometry and injected retro-orbitally into the lethally irradiated mice (one donor to five recipients). Recipient mice were housed in a barrier facility under pathogen-free conditions before and after bone marrow transplantation. After bone marrow transplantation, mice were provided autoclaved acidified water with antibiotics (trimethoprim-sulfamethoxazole) and were fed autoclaved food. Mice were used for further experiments eight weeks after bone marrow reconstitution.
Hematology
Blood counts of WT/Het or CFTR Δ508 littermates were taken via retro-orbital bleeding and analyzed by an automatic analyzer (Hemavet 950FS, DREW Scientific). Mice were anesthetized by the inhalation of isoflurane/oxygen gas mixture during the bleeding.
Flow cytometry
Blood was obtained by cardiac puncture with an EDTA-coated syringe. Red blood cells were lysed in RBC Lysis Buffer according to the manufacturer's protocol. Lungs were lavaged with PBS containing 2mM EDTA, dissociated by gentleMACS™ Dissociator (Miltenyi), and filtered through a 70 μm strainer. Ten centimeters of small intestines from the end of stomach, which contains duodenum and a part of jejunum, were collected. For preparation of lamina propria (LP) cells, fat and connective tissue were removed from intestines. Intestines were opened longitudinally, cut into 1-cm pieces and washed 3× 10 minutes in HBSS containing 5% FBS, 2 mM EDTA, 100 mM N-acetyl cysteine, and 10 mM HEPES to remove mucus and epithelial cells. Tissue was digested with 1 mg/mL collagenase VIII (Sigma) and 20 μg/mL DNase I (Sigma) for 20 minutes at 37°C. Digested material was dissociated by gentleMACS™ Dissociator (Miltenyi) and filtered through a 70 μm strainer. Bone marrow cells were collected from both femurs and tibias. In some experiments, mice were challenged intranasally with mouse CCL2 100ng/mouse 12 hours prior to the harvest. Blood was collected via retro-orbital bleeding.
BAL was collected by intratracheal lavage with PBS before the collection of lung.
All samples were collected in PBS with 2 mM EDTA to prevent cation-dependent cell-cell adhesion, and were stored on ice during transportation, staining and analysis. Cells were resuspended in 100 μl flow staining buffer (1% BSA and 0.1% sodium azide in PBS). Cells were stained with Ghost Dye™ Violet 510 for analysis of viability. Fcγ receptors were blocked for 15 min and surface antigens on cells were stained for 30 min at 4°C with directly conjugated fluorescent antibodies (flow cytometry antibody panels, Table S2 ). Forward-and side-scatter parameters were used for exclusion of doublets from analysis. Cell fluorescence was assessed with a LSRII (BD Biosciences) and was analyzed with FlowJo (BD, version 10.4). Gating scheme was shown in fig. S1-3. Lung and LP monocytes or macrophages were normalized by blood monocytes to eliminate the reconstructive rate difference of WT and CFTR Δ508 BM after BMT.
Histology
Intestines were rinsed, opened on the anti-mesenteric side, cut into three strips, and placed in parallel on biopsy pad in a cassette. Samples were then fixed in zinc formalin, embedded in paraffin, and cut into 3-to 5-μm sections. The tissues were stained with hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS) for histological assessment by a single investigator who was blinded to the experimental design. Slides were digitized on AxioScan Z1 slide scanner using 40× 0.95NA objective (Zeiss). The height of intestinal villi and crypt and the percentage of intestinal crypts that contain mucus was quantified in ZEN Blue software (Zeiss).
Microfluidic perfusion assay
The assembly of the microfluidic devices used in this study and the coating of coverslips with recombinant mouse P-selectin-Fc and ICAM-1-Fc has been described previously (37, (54) (55) (56) .
Briefly, cleaned coverslips were coated with P-selectin-Fc (2 μg ml -1 ) and ICAM-1-Fc (10 μg ml -1 ) for 2 hours and then blocked for 1 hour with casein (1%) at RT. After coating, coverslips were sealed to polydimethylsiloxane (PDMS) chips by magnetic clamps to create flow chamber channels ~29 μm high and ~300 μm across. By modulating the pressure between the inlet well and the outlet reservoir, 6 dyn cm -2 wall shear stress was applied in all experiments.
For the in vitro adhesion assay of monocytes, isolated mouse BM cells (10 7 cells ml -1 ) from WT or CFTR ΔF508 mice were incubated with PE-conjugated anti-CD115 antibody and AF647-conjugated anti-Ly6G antibody for 10 minutes at RT and perfused through the microfluidic device over a substrate of recombinant mouse P-selectin-Fc and recombinant mouse ICAM-1-Fc at a wall shear stress of 6 dyn cm -2 . After cells were rolling on the substrate, 100 ng ml -1 mouse CCL2 was perfused. The processes of rolling and arrest were recorded by epifluorescence microscopy using an Olympus IX71 inverted microscope equipped with a 40× 0.95NA objective.
Statistics
Statistical analysis was performed with Prism 6 (GraphPad). Data are presented as survival curve ( Fig. 1A,3A ,4A) and mean ± SD ( Fig. 1B-F ,I,J,2B,C,E,3C,D,F,4C-E,5B-G). Survival curves were compared using the Gehan-Breslow-Wilcoxon test. The means for the data sets were compared using the student t-tests with equal variances. P values less than 0.05 were considered significant.
Supplementary Materials
Fig. S1. The gating scheme of blood flow cytometry assay. Fig. S2 . The gating scheme of lung cytometry assay. Fig. S3 . The gating scheme of LPL cytometry assay. Table S1 . Reconstitution rate of monocytes after BMT. Table S2 . Panels of flow cytometry assay. Figure S1   Fig. S1 . The gating scheme of blood flow cytometry assay. Singlets and live cells were gated first. Mature cells were gated as CD117 -. Monocytes were gated as CD115 + , Ly6G -, CD11b + , NK1.1 -, CD19 -, TCRβ -. Monocytes were identified as Ly6C hi classical monocytes and Ly6C low patrolling monocytes. In the mixed BMT mice, WT or CFTR ΔF508 monocytes were CD45.1 + or CD45.2 + , respectively. Monocytes were gated as CD19 -, TCRβ -, Ly6G -, NK1.1 -, CD115 + , CD11b + , CD11c -.
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Figure S2
Macrophages were gated as CD19 -, TCRβ -, Ly6G -, NK1.1 -, CD115 -, F4/80 + , CD11b + .
Monocytes were identified as Ly6C hi classical monocytes and Ly6C low patrolling monocytes. In the mixed BMT mice, WT or CFTR ΔF508 monocytes were CD45.1 + or CD45.2 + , respectively. The BAL gating is the same as lung gating. Monocytes were gated as TCRβ -, Ly6G -, CD19 -, NK1.1 -, CD4 -, CD8a -, CD11b + , F4/80 -, CD11c -.
Figure S3
Macrophages were gated as TCRβ -, Ly6G -, CD19 -, NK1.1 -, CD4 -, CD8a -, CD11b + , F4/80 + .
Monocytes were identified as Ly6C hi classical monocytes and Ly6C low patrolling monocytes. In the mixed BMT mice, WT or CFTR ΔF508 monocytes were CD45.1 + or CD45.2 + , respectively. 
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